Detection of T Cell Cytokine Production as a Tool for Monitoring Immunotherapy

por John, J., Pandha, H., Dalgleish, A. G.
Publicado 2000

HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)

por Plowright, L, Harrington, K J, Pandha, H S, Morgan, R
Publicado 2009

Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy

por Ismail, M, Bokaee, S, Davies, J, Harrington, K J, Pandha, H
Publicado 2009

Cancer in Blacks, Whites and Asians in a British Hospital

por Potter, J. F., Dawkins, D. M., Pandha, H. S., Beevers, D. G.
Publicado 1984

Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy

por Ismail, M, Bokaee, S, Morgan, R, Davies, J, Harrington, K J, Pandha, H
Publicado 2009

Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics

por Harrington, K.J., Vile, R.G., Melcher, A., Chester, J., Pandha, H.S.
Publicado 2010

Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naïve T-cell priming

por Merrick, A, Errington, F, Milward, K, O'Donnell, D, Harrington, K, Bateman, A, Pandha, H, Vile, R, Morrison, E, Selby, P, Melcher, A
Publicado 2005

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer

por Simpson, G R, Horvath, A, Annels, N E, Pencavel, T, Metcalf, S, Seth, R, Peschard, P, Price, T, Coffin, R S, Mostafid, H, Melcher, A A, Harrington, K J, Pandha, H S
Publicado 2012

Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites

por Jennings, VA, Ilett, EJ, Scott, KJ, West, EJ, Vile, R, Pandha, H, Harrington, K, Young, A, Hall, GD, Coffey, M, Selby, P, Errington-Mais, F, Melcher, AA
Publicado 2014

Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced...

por Bartlett, J B, Michael, A, Clarke, I A, Dredge, K, Nicholson, S, Kristeleit, H, Polychronis, A, Pandha, H, Muller, G W, Stirling, D I, Zeldis, J, Dalgleish, A G
Publicado 2004

Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer

por Mansfield, D C, Kyula, J N, Rosenfelder, N, Chao-Chu, J, Kramer-Marek, G, Khan, A A, Roulstone, V, McLaughlin, M, Melcher, A A, Vile, R G, Pandha, H S, Khoo, V, Harrington, K J
Publicado 2016

Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial

por Staehler, M, Motzer, R J, George, D J, Pandha, H S, Donskov, F, Escudier, B, Pantuck, A J, Patel, A, DeAnnuntis, L, Bhattacharyya, H, Ramaswamy, K, Zanotti, G, Lin, X, Lechuga, M, Serfass, L, Paty, J, Ravaud, A
Publicado 2018

Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study

por Larkin, S E T, Johnston, H E, Jackson, T R, Jamieson, D G, Roumeliotis, T I, Mockridge, C I, Michael, A, Manousopoulou, A, Papachristou, E K, Brown, M D, Clarke, N W, Pandha, H, Aukim-Hastie, C L, Cragg, M S, Garbis, S D, Townsend, P A
Publicado 2016